Shares of Novartis India settled 1.04% down at Rs650.50 apiece on BSE on Monday. Photo: BloombergNew Delhi: Novartis India on Monday reported a 43.82% increase in net profit at Rs18.74 crore for the third quarter ended December 2017. The company had posted a net profit of Rs13.03 crore in the same period of the previous fiscal. Jawed Zia is currently head of pharmaceuticals, Novartis India. Shares of Novartis India settled 1.04% down at Rs650.50 apiece on BSE on Monday.

Source: Mint January 29, 2018 12:00 UTC